MIG
HZNP

Mariner Investment Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mariner Investment Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,000
Closed -$52K – 249
2015
Q2 		$52K Buy
+10,000
New +$305K 0.01% 192

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Mariner Investment Group's HZNP Position: Q2 2016 in Review

Mariner Investment Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2016, closing a stake of 169,700 shares — an estimated $2.81M sold.

Mariner Investment Group first reported a position in HZNP in Q3 2014 and held it in 6 quarters. The position peaked at $2.81M in Q1 2016. 198 funds tracked by Wall St. Rank hold HZNP as of Q2 2016.

  • Mariner Investment Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 169,700 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2016, an estimated $2.81M.
  • Mariner Investment Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 6 quarters.
  • Mariner Investment Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.81M in Q1 2016.
  • 198 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.